BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain T, Sharma P, Are AC, Vickers SM, Dudeja V. New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries. Front Immunol 2021;12:622064. [PMID: 33708214 DOI: 10.3389/fimmu.2021.622064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Vivarelli S, Falzone L, Leonardi GC, Salmeri M, Libra M. Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review). Int J Oncol 2021;59:75. [PMID: 34396439 DOI: 10.3892/ijo.2021.5255] [Reference Citation Analysis]
2 Sevcikova A, Izoldova N, Stevurkova V, Kasperova B, Chovanec M, Ciernikova S, Mego M. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy. Int J Mol Sci 2022;23:488. [PMID: 35008915 DOI: 10.3390/ijms23010488] [Reference Citation Analysis]
3 Bouferraa Y, Chedid A, Amhaz G, El Lakkiss A, Mukherji D, Temraz S, Shamseddine A. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges. Int J Mol Sci 2021;22:8036. [PMID: 34360802 DOI: 10.3390/ijms22158036] [Reference Citation Analysis]
4 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
5 Das SP, Ahmed SM, Naik B, Laha S, Bejai V. The human fungal pathogen Malassezia and its role in cancer. Fungal Biology Reviews 2021;38:9-24. [DOI: 10.1016/j.fbr.2021.08.002] [Reference Citation Analysis]
6 Tortora SC, Bodiwala VM, Quinn A, Martello LA, Vignesh S. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences. World J Gastrointest Oncol 2022; 14(2): 375-395 [DOI: 10.4251/wjgo.v14.i2.375] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ibragimova S, Ramachandran R, Ali FR, Lipovich L, Ho SB. Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis. Front Cell Dev Biol 2021;9:725821. [PMID: 34869313 DOI: 10.3389/fcell.2021.725821] [Reference Citation Analysis]
8 Mekadim C, Skalnikova HK, Cizkova J, Cizkova V, Palanova A, Horak V, Mrazek J. Dysbiosis of skin microbiome and gut microbiome in melanoma progression. BMC Microbiol 2022;22:63. [PMID: 35216552 DOI: 10.1186/s12866-022-02458-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Stella GM, Scialò F, Bortolotto C, Agustoni F, Sanci V, Saddi J, Casali L, Corsico AG, Bianco A. Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review. Cancers 2022;14:3131. [DOI: 10.3390/cancers14133131] [Reference Citation Analysis]
10 Russell BL, Sooklal SA, Malindisa ST, Daka LJ, Ntwasa M. The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy. Front Oncol 2021;11:641428. [PMID: 34268109 DOI: 10.3389/fonc.2021.641428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Saha MR, Dey P. Pharmacological benefits of Acacia against metabolic diseases: intestinal-level bioactivities and favorable modulation of gut microbiota. Arch Physiol Biochem 2021;:1-17. [PMID: 34411504 DOI: 10.1080/13813455.2021.1966475] [Reference Citation Analysis]
12 Jain T, Dudeja V. Hiding in Plain Sight: A Novel Microbial Driver for Colorectal Cancer? Cancer Discov 2022;12:1838-40. [PMID: 35929130 DOI: 10.1158/2159-8290.CD-22-0612] [Reference Citation Analysis]
13 Sharma R, Kannourakis G, Prithviraj P, Ahmed N. Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma. Front Med 2022;9:766869. [DOI: 10.3389/fmed.2022.766869] [Reference Citation Analysis]
14 Hyman M, Bradley E. Food, Medicine, and Function. Physical Medicine and Rehabilitation Clinics of North America 2022. [DOI: 10.1016/j.pmr.2022.04.001] [Reference Citation Analysis]
15 Sholl J, Sepich-Poore GD, Knight R, Pradeu T. Redrawing therapeutic boundaries: microbiota and cancer. Trends Cancer 2021:S2405-8033(21)00225-9. [PMID: 34844910 DOI: 10.1016/j.trecan.2021.10.008] [Reference Citation Analysis]
16 Vaish U, Jain T, Are AC, Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting. Int J Mol Sci 2021;22:13408. [PMID: 34948209 DOI: 10.3390/ijms222413408] [Reference Citation Analysis]
17 Veninga V, Voest EE. Tumor organoids: Opportunities and challenges to guide precision medicine. Cancer Cell 2021;39:1190-201. [PMID: 34416168 DOI: 10.1016/j.ccell.2021.07.020] [Reference Citation Analysis]
18 Dunn KA, Macdonald T, Rodrigues GJ, Forbrigger Z, Bielawski JP, Langille MG, Van Limbergen J, Kulkarni K. Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense. Front Cell Infect Microbiol 2022;12:924707. [DOI: 10.3389/fcimb.2022.924707] [Reference Citation Analysis]
19 Li Y, Ye Z, Zhu J, Fang S, Meng L, Zhou C. Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State. Front Immunol 2022;13:844335. [DOI: 10.3389/fimmu.2022.844335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Roberto M, Carconi C, Cerreti M, Schipilliti FM, Botticelli A, Mazzuca F, Marchetti P. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon? Front Immunol 2021;12:704942. [PMID: 34489956 DOI: 10.3389/fimmu.2021.704942] [Reference Citation Analysis]
21 Rinninella E, Raoul P, Cintoni M, Palombaro M, Pulcini G, Gasbarrini A, Mele MC. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies. Microorganisms 2021;9:1469. [PMID: 34361904 DOI: 10.3390/microorganisms9071469] [Reference Citation Analysis]
22 Zhou X, Kandalai S, Hossain F, Zheng Q. Tumor microbiome metabolism: A game changer in cancer development and therapy. Front Oncol 2022;12:933407. [DOI: 10.3389/fonc.2022.933407] [Reference Citation Analysis]
23 Lau HC, Hsueh CY, Gong H, Sun J, Huang HY, Zhang M, Zhou L. Oropharynx microbiota transitions in hypopharyngeal carcinoma treatment of induced chemotherapy followed by surgery. BMC Microbiol 2021;21:310. [PMID: 34753420 DOI: 10.1186/s12866-021-02362-4] [Reference Citation Analysis]
24 Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, Hasanpoor Z, Zadeh FA, Kahrizi MS. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03492-7] [Reference Citation Analysis]
25 Khan A, Ostaku J, Aras E, Safak Seker UO. Combating Infectious Diseases with Synthetic Biology. ACS Synth Biol 2022;11:528-37. [PMID: 35077138 DOI: 10.1021/acssynbio.1c00576] [Reference Citation Analysis]